1. Home
  2. PRME vs BVS Comparison

PRME vs BVS Comparison

Compare PRME & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$4.01

Market Cap

601.1M

Sector

Health Care

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$7.53

Market Cap

508.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
BVS
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
601.1M
508.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
PRME
BVS
Price
$4.01
$7.53
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$9.31
$13.33
AVG Volume (30 Days)
3.8M
289.0K
Earning Date
11-07-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.15
Revenue
$5,977,000.00
$563,829,000.00
Revenue This Year
$111.80
N/A
Revenue Next Year
N/A
$7.11
P/E Ratio
N/A
$49.19
Revenue Growth
647.13
1.58
52 Week Low
$1.11
$5.81
52 Week High
$6.94
$11.75

Technical Indicators

Market Signals
Indicator
PRME
BVS
Relative Strength Index (RSI) 49.51 53.55
Support Level $3.95 $7.02
Resistance Level $4.42 $7.70
Average True Range (ATR) 0.31 0.31
MACD 0.10 -0.01
Stochastic Oscillator 65.09 59.87

Price Performance

Historical Comparison
PRME
BVS

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: